Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Dhaygude

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Autoimmunity|October 30, 2009
Mechanisms and markers of vascular damage in ANCA-associated vasculitisMarion Haubitz, Ajay Dhaygude, Alexander Woywodt
BMJ Case Reports|June 10, 2022
Monoclonal gammopathy of undetermined significance causing large vessel vasculitisEdward George Alcorn, Lauren Floyd, Ajay Dhaygude
Plos One|March 7, 2024
Developing a disease-specific patient reported outcome measure to enhance understanding of the lived experiences of ANCA associated vasculitis: A protocol paperLauren Floyd, Ajay Dhaygude, Sandip Mitra, et al.
Current Stem Cell Research & Therapy|June 10, 2010
Circulating endothelial cells: markers and mediators of vascular damageUta Erdbruegger, Ajay Dhaygude, Marion Haubitz, et al.
Kidney360|April 4, 2022
Glucocorticoid Therapy in ANCA Vasculitis: Using the Glucocorticoid Toxicity Index as an Outcome MeasureLauren Floyd, Adam Morris, Miland Joshi, et al.
NDT Plus|May 8, 2015
A pilot in distressSophie Bennett, Nicos Mitsides, Ajay Dhaygude, et al.
Clinical Kidney Journal|August 31, 2017
Infectious complications of rituximab therapy in renal diseaseAndrew Nixon, Leanne Ogden, Alexander Woywodt, et al.
Rheumatology (Oxford, England)|April 12, 2026
Comment on: A systematic review of patient-reported outcome measures in patients with ANCA-associated vasculitis: replyLauren Floyd, Ajay Dhaygude, Sandip Mitra, et al.
European Journal of Ophthalmology|April 25, 2019
A complex case of haemodialysis induced increased intraocular pressureSalma Babiker, Mohamed E Elsayed, Ajay Dhaygude, et al.
NDT Plus|May 8, 2015
Out of the blueAjay Dhaygude, Patrick MacDowall, Robert A Coward, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Autoimmunity|October 30, 2009
Mechanisms and markers of vascular damage in ANCA-associated vasculitisMarion Haubitz, Ajay Dhaygude, Alexander Woywodt
BMJ Case Reports|June 10, 2022
Monoclonal gammopathy of undetermined significance causing large vessel vasculitisEdward George Alcorn, Lauren Floyd, Ajay Dhaygude
Plos One|March 7, 2024
Developing a disease-specific patient reported outcome measure to enhance understanding of the lived experiences of ANCA associated vasculitis: A protocol paperLauren Floyd, Ajay Dhaygude, Sandip Mitra, et al.
Current Stem Cell Research & Therapy|June 10, 2010
Circulating endothelial cells: markers and mediators of vascular damageUta Erdbruegger, Ajay Dhaygude, Marion Haubitz, et al.
Kidney360|April 4, 2022
Glucocorticoid Therapy in ANCA Vasculitis: Using the Glucocorticoid Toxicity Index as an Outcome MeasureLauren Floyd, Adam Morris, Miland Joshi, et al.
NDT Plus|May 8, 2015
A pilot in distressSophie Bennett, Nicos Mitsides, Ajay Dhaygude, et al.
Clinical Kidney Journal|August 31, 2017
Infectious complications of rituximab therapy in renal diseaseAndrew Nixon, Leanne Ogden, Alexander Woywodt, et al.
Rheumatology (Oxford, England)|April 12, 2026
Comment on: A systematic review of patient-reported outcome measures in patients with ANCA-associated vasculitis: replyLauren Floyd, Ajay Dhaygude, Sandip Mitra, et al.
European Journal of Ophthalmology|April 25, 2019
A complex case of haemodialysis induced increased intraocular pressureSalma Babiker, Mohamed E Elsayed, Ajay Dhaygude, et al.
NDT Plus|May 8, 2015
Out of the blueAjay Dhaygude, Patrick MacDowall, Robert A Coward, et al.
Pageof 3